Narrow search
Showing 1 - 10 of 2,060
Cover Image
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron; Zhang, Yuting - In: Health economics 23 (2014) 11, pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176
Cover Image
Anticipatory behavior in response to Medicare Part D's coverage gap
Kaplan, Cameron M.; Zhang, Yuting - In: Health economics 26 (2017) 3, pp. 338-351
Persistent link: https://www.econbiz.de/10011815376
Cover Image
Should pharmaceutical costs be curbed?
Brekke, Kurt R.; Dalen, Dag Morten; Strøm, Steinar - In: Nordic economic policy review (2012) 2, pp. 247-273
Persistent link: https://www.econbiz.de/10010379568
Cover Image
What effect did Medicare Part D have on SSDI medicare beneficiaries? : a look at prescription drug coverage, utilization, and expenditures
Alfrey, Brett - In: American Journal of Health Economics : AJHE official … 10 (2024) 3, pp. 437-469
Persistent link: https://www.econbiz.de/10014633598
Cover Image
Physician responses to insurance benefit restrictions : the case of ophthalmology
Abiona, Olukorede; Haywood, Phil; Yu, Serena; Hall, Jane; … - In: Health economics 33 (2024) 5, pp. 911-928
Persistent link: https://www.econbiz.de/10014514601
Cover Image
The impact of a national formulary expansion on diabetics
McNamara, Cici; Serna, Natalia - In: Health economics 31 (2022) 11, pp. 2311-2332
Persistent link: https://www.econbiz.de/10013461821
Cover Image
Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?
Cook, Amanda C.; Sirmans, E. Tice; Wells, Brenda - In: The Geneva papers on risk and insurance - issues and … 49 (2024) 1, pp. 212-226
Persistent link: https://www.econbiz.de/10014446859
Cover Image
Moral hazard in drug purchases
Verho, Jouko; Harju, Jarkko - 2023
We study the moral hazard effects of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out-of-pocket drug costs decrease substantially. Our results...
Persistent link: https://www.econbiz.de/10014289803
Cover Image
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
Liu, Judith; Zhang, Yuting; Kaplan, Cameron M. - In: Health economics 32 (2023) 3, pp. 639-653
Persistent link: https://www.econbiz.de/10014266837
Cover Image
The impact of Medicare Part D on Medicare-Medicaid dual-eligible benficiaries' prescription utilization and expenditurs
Basu, Anirban; Yin, Wesley; Alexander, G. Caleb - 2008
Persistent link: https://www.econbiz.de/10003770583